drugset / Trial / NCT00663286

A Clinical Trial Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris

NCT00663286

Phase 3 Completed 1399 enrolled Dow Pharmaceutical Sciences
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the effectiveness of IDP-110 in treating patients with acne vulgaris.

Timeline

Start
2006-10
Primary completion
2007-08
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Benzoyl Peroxide Other / unclassified Topical
Comparator Clindamycin Unknown Topical
Subject IDP-110 Unknown Topical

Indications